A panel containing PD-1, IL-2Rα, IL-10, and CA15-3 as a biomarker to discriminate breast cancer from benign breast disease

References

• SiegelRLMillerKDJemalA Cancer statistics, 2017 CA Cancer J Clin 2017 67 1 7 30 28055103
   PubMed Web of Science ®Google Scholar
• KerlikowskeKZhuWHubbardRABreast Cancer Surveillance Consortium Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy JAMA Intern Med 2013 173 9 807 816 23552817
   PubMed Web of Science ®Google Scholar
• SaslowDBoetesCBurkeWAmerican Cancer Society Breast Cancer Advisory Group American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography CA Cancer J Clin 2007 57 2 75 89 17392385
   PubMed Web of Science ®Google Scholar
• KriegeMBrekelmansCTBoetesCMagnetic Resonance Imaging Screening Study Group Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition N Engl J Med 2004 351 5 427 437 15282350
   PubMed Web of Science ®Google Scholar
• StieberPNagelDBlankenburgI Diagnostic efficacy of CA 15-3 and CEA in the early detection of metastatic breast cancer – a retrospective analysis of kinetics on 743 breast cancer patients Clin Chim Acta 2015 448 228 231 26160053
   PubMed Web of Science ®Google Scholar
• HamamRHamamDAlsalehKA Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers Cell Death Dis 2017 8 9 e3045 28880270
   PubMed Web of Science ®Google Scholar
• Chandra GuptaSNandan TripathiY Potential of long non-coding RNAs in cancer patients: from biomarkers to therapeutic targets Int J Cancer 2017 140 9 1955 1967 27925173
   PubMed Web of Science ®Google Scholar
• TrecateGSinuesPMOrlandiR Noninvasive strategies for breast cancer early detection Future Oncol 2016 12 11 1395 1441 27044539
   PubMed Web of Science ®Google Scholar
• Alix-PanabièresCPantelK Clinical applications of circulating tumor cells and circulating tumor DNA as liquid biopsy Cancer Discov 2016 6 5 479 491 26969689
   PubMed Web of Science ®Google Scholar
• ZhangLXuYJinX A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer Breast Cancer Res Treat 2015 154 2 423 434 26476723
   PubMed Web of Science ®Google Scholar
• ShakerOMaherMNassarYMorcosGGadZ Role of microRNAs -29b-2, -155, -197 and -205 as diagnostic biomarkers in serum of breast cancer females Gene 2015 560 1 77 82 25644077
   PubMed Web of Science ®Google Scholar
• MishraSSrivastavaAKSumanSKumarVShuklaY Circulating miRNAs revealed as surrogate molecular signatures for the early detection of breast cancer Cancer Lett 2015 369 1 67 75 26276721
   PubMed Web of Science ®Google Scholar
• ShenJHuQSchrauderM Circulating miR-148b and miR-133a as biomarkers for breast cancer detection Oncotarget 2014 5 14 5284 5294 25051376
   PubMedGoogle Scholar
• ChanMLiawCSJiSM Identification of circulating microRNA signatures for breast cancer detection Clin Cancer Res 2013 19 16 4477 4487 23797906
   PubMed Web of Science ®Google Scholar
• NassarFJNasrRTalhoukR MicroRNAs as biomarkers for early breast cancer diagnosis, prognosis and therapy prediction Pharmacol Ther 2017 172 34 49 27916656
   PubMed Web of Science ®Google Scholar
• UehiroNSatoFPuF Circulating cell-free DNA-based epigenetic assay can detect early breast cancer Breast Cancer Res 2016 18 1 129 27993161
   PubMed Web of Science ®Google Scholar
• ShanMYinHLiJ Detection of aberrant methylation of a six-gene panel in serum DNA for diagnosis of breast cancer Oncotarget 2016 7 14 18485 18494 26918343
   PubMedGoogle Scholar
• MadhavanDWallwienerMBentsK Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis Breast Cancer Res Treat 2014 146 1 163 174 24838941
   PubMed Web of Science ®Google Scholar
• SzpechcinskiARudzinskiPKupisWLangfortROrlowskiTChorostowska-WynimkoJ Plasma cell-free DNA levels and integrity in patients with chest radiological findings: NSCLC versus benign lung nodules Cancer Lett 2016 374 2 202 207 26854716
   PubMed Web of Science ®Google Scholar
• SzpechcinskiAChorostowska-WynimkoJStruniawskiR Cell-free DNA levels in plasma of patients with non-small-cell lung cancer and inflammatory lung disease Br J Cancer 2015 113 3 476 483 26125447
   PubMed Web of Science ®Google Scholar
• ChenXChenHDaiM Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions Oncotarget 2016 7 24 36622 36631 27153558
   PubMedGoogle Scholar
• YangLCuiXZhangN Comprehensive lipid profiling of plasma in patients with benign breast tumor and breast cancer reveals novel biomarkers Anal Bioanal Chem 2015 407 17 5065 5077 25651902
   PubMed Web of Science ®Google Scholar
• MoonPGLeeJEChoYE Identification of developmental endothelial locus-1 on circulating extracellular vesicles as a novel bio-marker for early breast cancer detection Clin Cancer Res 2016 22 7 1757 1766 26603257
   PubMed Web of Science ®Google Scholar
• ŁawickiSZajkowskaMGłażewskaEKBędkowskaGESzmitkowskiM Plasma levels and diagnostic utility of VEGF, MMP-9, and TIMP-1 in the diagnosis of patients with breast cancer Onco Targets Ther 2016 9 911 919 26966379
   PubMed Web of Science ®Google Scholar
• ChenDSMellmanI Elements of cancer immunity and the cancer-immune set point Nature 2017 541 7637 321 330 28102259
   PubMed Web of Science ®Google Scholar
• Vanpouille-BoxCLhuillierCBezuL Trial watch: immune checkpoint blockers for cancer therapy Oncoimmunology 2017 6 11 e1373237 29147629
   PubMed Web of Science ®Google Scholar
• NishinoMRamaiyaNHHatabuHHodiFS Monitoring immune-checkpoint blockade: response evaluation and biomarker development Nat Rev Clin Oncol 2017 14 11 655 668 28653677
   PubMed Web of Science ®Google Scholar
• MazzaschiGMadedduDFalcoA Low PD-1 expression in cytotoxic CD8+ tumor-infiltrating lymphocytes confers an immune-privileged tissue microenvironment in NSCLC with a prognostic and predictive value Clin Cancer Res 2018 24 2 407 419 29074606
   PubMed Web of Science ®Google Scholar
• KollmannDSchweigerTSchwarzS PD1-positive tumor-infiltrating lymphocytes are associated with poor clinical outcome after pulmonary metastasectomy for colorectal cancer Oncoimmunology 2017 6 9 e1331194 28932634
   PubMed Web of Science ®Google Scholar
• SorensenSFDemuthCWeberBSorensenBSMeldgaardP Increase in soluble PD-1 is associated with prolonged survival in patients with advanced EGFR-mutated non-small cell lung cancer treated with erlotinib Lung Cancer 2016 100 77 84 27597284
   PubMed Web of Science ®Google Scholar
• DuchnowskaRPęksaRRadeckaBPolish Brain Metastasis Consortium Immune response in breast cancer brain metastases and their microenvironment: the role of the PD-1/PD-L axis Breast Cancer Res 2016 18 1 43 27117582
   PubMed Web of Science ®Google Scholar
• WakiKYamadaTYoshiyamaK PD-1 expression on peripheral blood T-cell subsets correlates with prognosis in non-small cell lung cancer Cancer Sci 2014 105 10 1229 1235 25117757
   PubMed Web of Science ®Google Scholar
• SunSFeiXMaoY PD-1(+) immune cell infiltration inversely correlates with survival of operable breast cancer patients Cancer Immunol Immunother 2014 63 4 395 406 24514954
   PubMed Web of Science ®Google Scholar
• WangXRickertMGarciaKC Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors Science 2005 310 5751 1159 1163 16293754
   PubMed Web of Science ®Google Scholar
• YangZZGroteDMZiesmerSC Soluble IL-2Rα facilitates IL-2-mediated immune responses and predicts reduced survival in follicular B-cell non-Hodgkin lymphoma Blood 2011 118 10 2809 2820 21719603
   PubMed Web of Science ®Google Scholar
• NakaseKKitaKMiwaH Clinical and prognostic significance of cytokine receptor expression in adult acute lymphoblastic leukemia: interleukin-2 receptor alpha-chain predicts a poor prognosis Leukemia 2007 21 2 326 332 17205058
   PubMed Web of Science ®Google Scholar
• HashimotoYYokohamaASaitohA Prognostic importance of the soluble form of IL-2 receptorα (sIL-2Rα) and its relationship with surface expression of IL-2Rα (CD25) of lymphoma cells in diffuse large B-cell lymphoma treated with CHOP-like regimen with or without rituximab: a retrospective analysis of 338 cases J Clin Exp Hematop 2013 53 3 197 205 24369221
   PubMedGoogle Scholar
• GuptaMStensonMO’ByrneM Comprehensive serum cytokine analysis identifies IL-1RA and soluble IL-2Rα as predictors of event-free survival in T-cell lymphoma Ann Oncol 2016 27 1 165 172 26487586
   PubMed Web of Science ®Google Scholar
• KorobeinikovaEMyrzaliyevaDUgenskieneR The prognostic value of IL10 and TNF alpha functional polymorphisms in premenopausal early-stage breast cancer patients BMC Genet 2015 16 70 26112140
   PubMed Web of Science ®Google Scholar
• EngelsCCCharehbiliAvan de VeldeCJ The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis Breast Cancer Res Treat 2015 149 3 587 596 25616355
   PubMed Web of Science ®Google Scholar
• LiuCWuSMengX Predictive value of peripheral regulatory T cells in non-small cell lung cancer patients undergoing radiotherapy Oncotarget 2017 8 26 43427 43438 28624781
   PubMedGoogle Scholar
• LiYGaoPYangJYuHZhuYSiW Relationship between IL-10 expression and prognosis in patients with primary breast cancer Tumour Biol 2014 35 11 11533 11540 25129439
   PubMedGoogle Scholar
• BrownJRWimberlyHLanninDRNixonCRimmDLBossuytV Multiplexed quantitative analysis of CD3, CD8, and CD20 predicts response to neoadjuvant chemotherapy in breast cancer Clin Cancer Res 2014 20 23 5995 6005 25255793
   PubMed Web of Science ®Google Scholar
• WestNRKostSEMartinSD Tumour-infiltrating FOXP3(+) lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer Br J Cancer 2013 108 1 155 162 23169287
   PubMed Web of Science ®Google Scholar
• SuYCaiHZhengY Associations of the transforming growth factor β/Smad pathway, body mass index, and physical activity with breast cancer outcomes: results from the Shanghai breast cancer study Am J Epidemiol 2016 184 7 501 509 27651382
   PubMed Web of Science ®Google Scholar
• BuschSAcarAMagnussonYGregerssonPRydénLLandbergG TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer Oncogene 2015 34 1 27 38 24336330
   PubMed Web of Science ®Google Scholar
• WangZKYangBLiuH Regulatory T cells increase in breast cancer and in stage IV breast cancer Cancer Immunol Immunother 2012 61 6 911 916 22116346
   PubMed Web of Science ®Google Scholar
• WolfAMWolfDSteurerMGastlGGunsiliusEGrubeck-LoebensteinB Increase of regulatory T cells in the peripheral blood of cancer patients Clin Cancer Res 2003 9 2 606 612 12576425
   PubMed Web of Science ®Google Scholar
• EdgeSBComptonCC The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM Ann Surg Oncol 2010 17 6 1471 1474 20180029
   PubMed Web of Science ®Google Scholar
• MacFarlaneAW4thJillabMPlimackER PD-1 expression on peripheral blood cells increases with stage in renal cell carcinoma patients and is rapidly reduced after surgical tumor resection Cancer Immunol Res 2014 2 4 320 331 24764579
   PubMed Web of Science ®Google Scholar
• SharpeAHPaukenKE The diverse functions of the PD1 inhibitory pathway Nat Rev Immunol 2018 18 3 153 167 28990585
   PubMed Web of Science ®Google Scholar
• HamidullahChangkijaBKonwarR Role of interleukin-10 in breast cancer Breast Cancer Res Treat 2012 133 1 11 21 22057973
   PubMed Web of Science ®Google Scholar
• KiyomiAMakitaMOzekiT Characterization and clinical implication of Th1/Th2/Th17 cytokines produced from three-dimensionally cultured tumor tissues resected from breast cancer patients Transl Oncol 2015 8 4 318 326 26310378
   PubMed Web of Science ®Google Scholar